NDC 70518-4506-01 - ORPHENADRINE CITRATE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 70518-4506
- Requested NDC
- 70518-4506-01
- Package NDCs from labels
- 70518-4506-0, 70518-4506-1, 70518-4506-3, 70518-4506-2, 70518-4506-4, 70518-4506-01
- Manufacturer
- REMEDYREPACK INC.
- Effective date
- 2026-08-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Orphenadrine Citrate Extended-Release Tablets Rx Only | REMEDYREPACK INC. | 2026-08-10 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 70518-4506-0 | ORPHENADRINE CITRATE | 14 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 14 | 3 | |
| 70518-4506-1 | ORPHENADRINE CITRATE | 14 in 1 BOTTLE, PLASTIC | TABLET, EXTENDED RELEASE | 14 | 3 | |
| 70518-4506-2 | ORPHENADRINE CITRATE | 50 in 1 BOX | TABLET, EXTENDED RELEASE | 50 | 3 | |
| 70518-4506-3 | ORPHENADRINE CITRATE | 1 in 1 POUCH | TABLET, EXTENDED RELEASE | 1 | 3 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Orphenadrine citrate | ORPHENADRINE CITRATE | Hikma Pharmaceuticals USA Inc. | ed406e8a-ec00-4711-ae2b-3c5af4f15438 | 2024-08-08 | Warnings, Adverse reactions | X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | RedPharm Drug | 1cff761d-e594-a9e6-e063-6394a90a1fd5 | 2024-07-11 | Warnings, Adverse reactions | 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Sandoz Inc | 239018ff-cec6-46de-ae9d-26c9ec034a32 | 2024-03-22 | Warnings, Adverse reactions | 994521 X0A40N8I4S |
| GENTEAL TEARS | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | A-S Medication Solutions | a2b715e9-332d-4f0b-b8e5-ebc000681586 | 2024-01-21 | Warnings | 3NXW29V3WO |
| Equate Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Wal-Mart Stores, Inc. | 91fb8fb5-b871-4535-e053-2995a90a9b16 | 2023-12-23 | Warnings | 3NXW29V3WO |
| Sunmark Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Strategic Sourcing Services LLC | 043ccc34-44ee-416a-88bc-f247774e9075 | 2023-12-23 | Warnings | 3NXW29V3WO |
| Rite Aid Eye Drops Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Rite Aid Corporation | fa1b5b66-9643-e9a7-e053-6394a90ae3cf | 2023-12-23 | Warnings | 3NXW29V3WO |
| Meijer Dry Eye Relief | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Meijer Distribution, Inc. | 9feaa5e2-6aca-96e8-e053-2a95a90a54bd | 2023-12-22 | Warnings | 3NXW29V3WO |
| Walgreens Multi-Symptom Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400, TETRAHYDROZOLINE HCL, ZINC SULFATE | Walgreen Co. | a03789ce-66bd-7b12-e053-2995a90af85a | 2023-12-20 | Warnings | 3NXW29V3WO |
| Walgreens Lubricant Eye Drops Preservative Free | DEXTRAN 70, HYPROMELLOSE | Walgreen Company | 9b383e41-e116-1c12-e053-2a95a90ab25f | 2023-12-20 | Warnings | 3NXW29V3WO |
| TopCare Health Dry Eye Relief Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | Topco Associates LLC | 9c617e34-fc66-1a5b-e053-2995a90ace2c | 2023-12-20 | Warnings | 3NXW29V3WO |
| HEB Dry Eye Eye Drops | GLYCERIN, HYPROMELLOSE, POLYETHYLENE GLYCOL 400 | HEB | f80023cf-8e42-780a-e053-6294a90a66cd | 2023-12-20 | Warnings | 3NXW29V3WO |
| GenTeal Tears (Moderate) | DEXTRAN 70, GLYCERIN, HYPROMELLOSE | Alcon Laboratories, Inc. | a2992597-3490-6a5c-be45-2b6fa15e1547 | 2023-12-15 | Warnings | 3NXW29V3WO |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Proficient Rx LP | cf620257-7497-44c1-9853-87f96d262fbd | 2023-12-01 | Warnings, Adverse reactions | ANDA040284 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Sagent Pharmaceuticals | c8d8596a-b81f-4b83-a2f3-a55922ca4a82 | 2023-11-14 | Warnings, Adverse reactions | X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Proficient Rx LP | 37e6a157-5d0d-4887-9a26-ed5521fb08e6 | 2019-11-01 | Warnings, Adverse reactions | 994521 X0A40N8I4S |
| Orphenadrine Citrate | ORPHENADRINE CITRATE | Actavis Pharma, Inc. | aec8ad3a-f717-4e74-b7b9-19debdaad79a | 2016-07-20 | Warnings, Adverse reactions | X0A40N8I4S |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.